Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences.
Adenovirus type 5 (Ad5) DNA packaging is initiated in a polar fashion from the left end of the genome. The packaging process is dependent on the cis-acting packaging domain located between nucleotides 230 and 380. Seven AT-rich repeats that direct packaging have been identified within this domain. A1, A2, A5, and A6 are the most important repeats functionally and share a bipartite sequence motif. Several lines of evidence suggest that there is a limiting trans-acting factor(s) that plays a role in packaging. Both cellular and viral proteins that interact with adenovirus packaging elements in vitro have been identified. In this study, we characterized a group of recombinant viruses that carry site-specific point mutations within a minimal packaging domain. The mutants were analyzed for growth properties in vivo and for the ability to bind cellular and viral proteins in vitro. Our results are consistent with a requirement of the viral IVa2 protein for DNA packaging via a direct interaction with packaging sequences. Our results also indicate that higher-order IVa2-containing complexes that form on adjacent packaging repeats in vitro are the complexes required for the packaging activity of these sites in vivo. Chromatin immunoprecipitation was used to study proteins that bind directly to the packaging sequences. These results demonstrate site-specific interaction of the viral IVa2 and L1 52/55K proteins with the Ad5 packaging domain in vivo. These results confirm and extend those previously reported and provide a framework on which to model the adenovirus assembly process.
Ostapchuk
Philomena
P
Department of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
Yang
Jihong
J
Auffarth
Ece
E
Hearing
Patrick
P
D000260:Adenoviruses, Human / Q000235:genetics / Q000502:physiology*; D001483:Base Sequence; D002460:Cell Line; D004261:DNA Replication; D004279:DNA, Viral / Q000096:biosynthesis / Q000235:genetics; D005814:Genes, Viral; D018398:Homeodomain Proteins; D006801:Humans; D046912:Multiprotein Complexes; D009687:Nuclear Proteins / Q000378:metabolism; D017354:Point Mutation; D011485:Protein Binding; D012097:Repressor Proteins / Q000378:metabolism; D012689:Sequence Homology, Nucleic Acid; D014157:Transcription Factors; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D015678:Viral Structural Proteins / Q000378:metabolism; D019065:Virus Assembly / Q000502:physiology
C080632:CUX1 protein, human; D004279:DNA, Viral; D018398:Homeodomain Proteins; D046912:Multiprotein Complexes; D009687:Nuclear Proteins; D012097:Repressor Proteins; D014157:Transcription Factors; D014764:Viral Proteins; D015678:Viral Structural Proteins; C056232:iva2 protein, adenovirus